• Title/Summary/Keyword: paddle

Search Result 167, Processing Time 0.027 seconds

Iatrogenic Spark Burn Injury to the Chest From a Transcutaneous Pacing Patch (경피적 심장 충격 장치의 사용으로 발생한 의인성 전기 화상의 증례 보고)

  • Choi, Jong Yun;Cha, Won Jin;Jung, Ee Room;Seo, Bommie Florence;Jung, Sung-No
    • Journal of the Korean Burn Society
    • /
    • v.24 no.2
    • /
    • pp.50-52
    • /
    • 2021
  • Iatrogenic electrical burns that occur from the use of a defibrillator, a paddle-type cardiac shock device, have been reported in various forms. Electrical burns are usually conducted directly through the skin and are more damaging than scald burns or contact burns. A transcutaneous cardiac pacing device is a patch-type cardiac shock device that automatically delivers a shock when an abnormal heart rhythm is detected. We introduce a unique case of iatrogenic electrical burns caused by the transcutaneous pacing patch of a cardiac shock device. Electrical energy was converted into a spark due to foreign bodies deposited around the patch, resulting in damage to the peripheral area of the skin.

Radial forearm free flap in a patient with an unusual radial artery variation: a case report

  • Menichini, Giulio;Calabrese, Sara;Alfonsi, Nicola;Innocenti, Marco
    • Archives of Plastic Surgery
    • /
    • v.48 no.6
    • /
    • pp.646-650
    • /
    • 2021
  • Head and neck reconstruction poses unique challenges in rehabilitating surgical defects in terms of integrity, function, and form. The radial forearm free flap (RFFF) has been widely used for defect coverage, especially in the head and neck area, but its versatility allows it to be used for soft-tissue reconstruction in various parts of the body. The vascular features of the flap are quite constant and reliable. Nevertheless, abnormalities of the forearm vascular tree have been described over the decades. We report a case of intraoral reconstruction after verrucous carcinoma recurrence in a 74-year-old woman with an unusual forearm flap, which we called the median forearm free flap, based on a median branch of the radial artery that was preoperatively detected using handheld Doppler ultrasonography. The distally located skin paddle was predominantly supplied by the aberrant median vessel with its perforators. The flap was thus safely harvested with this atypical pedicle. Successful reconstruction of the intraoral defect was achieved, with an uneventful postoperative course.

An analytical and numerical study of a vertically-discretized wavemaker (수직다열화된 조파장치의 해석해 개발 및 수치모형 실험)

  • Son, Sangyoung;Kim, Yeulwoo;Jung, Taehwa
    • Proceedings of the Korea Water Resources Association Conference
    • /
    • 2021.06a
    • /
    • pp.103-103
    • /
    • 2021
  • 실험실에서의 파랑생성에 흔히 사용되는 피스톤형 조파장치는 수심에 따라 유속이 동일하게 생성된다는 제약이 있어 주로 천해파의 생성에 적합한 것으로 알려져 있다. 본 연구에서는 이러한 제약조건 없이 다양한 유속분포의 파형을 생성하는 수직 다열화된 조파장치가 개발되었다. 우선, 수심방향으로 이산화된 각 패들(paddle)의 스트로크에 대해 선형해석해가 유도되었다. 개발된 해석해는 패들의 수 및 유속분포에 따라 기존의 피스톤형 혹은 플랩형 조파장치 해석해로 근사함이 밝혀짐으로써 포괄적으로 활용될 수 있음이 확인되었다. 즉 개발된 해석해를 활용하면 선택적으로 피스톤형 및 플랩형 조파성능이 구현될 수 있다. 더불어 개발된 해석해는 다상유체의 내부파 생성에도 확정되어 적용가능함이 확인되었다. 다음으로, 개발된 조파장치를 수치적으로 구현하였다. 오픈소스 3차원 수치모형인 OpenFOAM 중, 두 개 이상의 불연속 및 비압축 유체에 대한 Navier-Stokes 방정식을 해결하는 수치 모듈을 사용하여 제안된 수직다열화된 조파장치의 성능이 평가되었다. 이때 동적격자모델(olaDyMFlow)을 결합함으로써 개발된 조파장치 움직임이 물리적 조파장치와 흡사하도록 수치적으로 구현하였다. 모의결과, 여러 개의 다열화된 패들이 층류 흐름 조건에서 심해파를 효율적으로 생성시키고, 중간수심 파랑조건에서는 제안된 조파장치가 상대적으로 덜 유리함을 확인할 수 있었다. 마지막으로 공기, 기름 및 물 등 3상의 흐름조건에서 단 두 개의 패들을 활용하여 각각 내부파 및 표면파를 생성하되었으며, 모의 결과는 해석해과 비교됨으로써 개발된 조파장치의 성능이 검증되었다.

  • PDF

Semicircular Horizontal Approach in Breast Reduction: Clinical Experience in 38 Cases

  • Shin, Hee Su;Lee, Yong Hae;Jung, Sung Gyun;Lee, Doo Hyung;Roe, Young;Cha, Jong Hyun
    • Archives of Plastic Surgery
    • /
    • v.42 no.4
    • /
    • pp.446-452
    • /
    • 2015
  • Background Various techniques are used for performing breast reduction. Wise-pattern and vertical scar techniques are the most commonly employed approaches. However, a vertical scar in the mid-lower breast is prominent and aesthetically less pleasant. In contrast, a semicircular horizontal approach does not leave a vertical scar in the mid breast and transverse scars can be hidden in the inframammary fold. In this paper, we describe the experiences and results of semicircular horizontal breast reductions performed by a single surgeon. Methods Between September 1996 and October 2013, our senior author used this technique in 38 cases in the US and at our institution. We used a superiorly based semicircular incision, where the upper skin paddle was pulled down to the inframammary fold with the nipple-areola complex pulled through the keyhole. Results The average total reduction per breast was 584 g, ranging from 286 to 794 g. The inferior longitudinal pedicle was used in all the cases. The average reduction of the distance from the sternal notch to the nipple was 13 cm (range, 11-15 cm). The mean decrease in the bra cup size was 1.7 cup sizes (range, a decrease of 1 to 3). We obtained very satisfactory results with a less noticeable scar, no complication such as necrosis of the nipple or the skin flap, wound infection, aseptic necrosis of the breast tissue, or wound dehiscence. One patient had a small hematoma that resolved spontaneously. Conclusions This technique is straightforward and easy to learn, and offers a safe, effective, and predictable way for treating mammary hypertrophy.

A Study on Remediation of Heavy Metal Contaminated Soil using a Soil Electrolysis Apparatus with Spiral Paddle (나선형패들이 장착된 토양전기분해장치를 이용한 중금속 오염토양 정화에 관한 연구)

  • Lee, Jun-Hee;Choi, Young-Ik;Jung, Jin-Hee
    • Journal of Environmental Science International
    • /
    • v.26 no.6
    • /
    • pp.797-802
    • /
    • 2017
  • This study aimed to remove organic matter and heavy metals that could affect the recycling of soils contaminated by heavy metals, by means of electrolysis, carried out simultaneously with the leaching of the soil. To ensure better experimental equipment, a soil electrolysis apparatus, equipped with spiral paddles, was used to agitate the heavy-metal-contaminated soil effectively. The heavy-metal-contaminated soil was electrolyzed by varying the voltage to 5 V(Condition 1), 15 V(Condition 2), and 20 V(Condition 3), under the optimal operating conditions of the electrolysis apparatus, as determined through previous studies. The results showed that the pH of the electrolyte solution and the heavy-metal-contaminated soil, after electrolysis, tended to decrease with an increase in voltage. The highest removal efficiencies of TOC and $COD_{Cr}$ were 18.8% and 29.1%, 38.8% and 4.2%, and 33.3% and 50.0%, under conditions 1, 2 and 3, respectively. Heavy metals such as Cd and As were not detected in this experiment. The removal efficiencies of Cu, Pb and Cr were 4.7%, 8.3% and 2.1%, respectively, under Condition 1, while they were 42.9%, 15.2% and 22.1%, respectively, under Condition 2, and 4.7%, 23.0%, and 24.9%, respectively, under Condition 3. These results suggest that varying the voltage with the soil electrolysis apparatus for removing contaminants for the recycling of heavy-metal-contaminated soil allows the selective removal of contaminants. Therefore, the results of this study can be valuable as basic data for future studies on soil remediation.

Preparation and Characterization of Simvastatin Solid Dispersion using Aqueous Solvent

  • Kim, Kwang-Hyeon;Park, Jun-Bom;Choi, Won-Jae;Lee, Han-Seung;Kang, Chin-Yang
    • Journal of Pharmaceutical Investigation
    • /
    • v.41 no.4
    • /
    • pp.239-247
    • /
    • 2011
  • Simvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early and rate-limiting step in the biosynthesis of cholesterol. Simvastatin has good permeability, but it also has low solubility (BCS class II), which reduces its bioavailability. To overcome this problem, a solid dispersion is formed using a spray-dryer with polymeric material carrier to potentially enhance the dissolution rate and extend drug absorption. As carriers for solid dispersion, Gelucire$^{(R)}$44/14 and Gelucire$^{(R)}$ 50/13 are semisolid excipients that greatly improve the bioavailability of poorly-soluble drugs. To avoid any toxic effects of an organic solvent, we used aqueous medium to melt Tween$^{(R)}$ 80 and distilled water. The structural behaviors of the raw materials and the solid dispersion were analyzed by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD) and scanning electron microscopy (SEM). The DSC and PXRD data indicated that the crystalline structure of simvastatin was transformed to an amorphous structure through solid dispersion. Then, solid dispersion-based tablets containing 20 mg simvastatin were prepared with excipients. Dissolution tests were performed in distilled water and artificial intestinal fluid using the USP paddle II method. Compared with that of the commercial tablet (Zocor$^{(R)}$ 20 mg), the release of simvastatin from solid dispersion based-tablet was more efficient. Although the stability study is not complete, this solid dispersion system is expected to deliver poorly water-soluble drugs with enhanced bioavailability and less toxicity.

Orienting the superficial inferior epigastric artery (SIEA) pedicle in a stacked SIEA-deep inferior epigastric perforator free flap configuration for unilateral tertiary breast reconstruction

  • Yu, Ya-han;Ghorra, Dina;Bojanic, Christine;Aria, Oti N.;MacLennan, Louise;Malata, Charles M.
    • Archives of Plastic Surgery
    • /
    • v.47 no.5
    • /
    • pp.473-477
    • /
    • 2020
  • Superficial inferior epigastric artery (SIEA) flaps represent a useful option in autologous breast reconstruction. However, the short-fixed pedicle can limit flap inset options. We present a challenging flap inset successfully addressed by de-epithelialization, turnover, and counterintuitive rotation. A 47-year-old woman underwent left tertiary breast reconstruction with stacked free flaps using right deep inferior epigastric perforator and left SIEA vessels. Antegrade and retrograde anastomoses to the internal mammary (IM) vessels were preferred; additionally, the thoracodorsal vessels were unavailable due to previous latissimus dorsi breast reconstruction. Optimal shaping required repositioning of the lateral ends of the flaps superiorly, which would position the ipsilateral SIEA hemi-flap pedicle lateral to and out of reach of the IM vessels. This problem was overcome by turning the SIEA flap on its long axis, allowing the pedicle to sit medially with the lateral end of the flap positioned superiorly. The de-epithelialized SIEA flap dermis was in direct contact with the chest wall, enabling its fixation. This method of flap inset provides a valuable solution for medializing the SIEA pedicle while maintaining an aesthetically satisfactory orientation. This technique could be used in ipsilateral SIEA flap breast reconstructions that do not require a skin paddle, as with stacked flaps or following nipple-sparing mastectomy.

In Vitro Dissolution of Felodipine from Extended-Release Pellets (펠로디핀 방출연장형 펠렛의 용출 특성 평가)

  • Park, Jeong-Sook;Nam, Kyung-Wan;Shin, Kwang-Hyun;Park, Jong-Bum;Kim, Min-Soo;Hwang, Sung-Joo
    • Journal of Pharmaceutical Investigation
    • /
    • v.37 no.3
    • /
    • pp.193-196
    • /
    • 2007
  • This study aimed to evaluate and develop $Eudragit^{(R)}$-coated pellets based on the dissolution using the paddle method. As coating materials, two types of $Eudragit^{(R)}$ were applied to obtain either sustained release form or fast released form. The dissolution test was carried out in phosphate buffer solution (pH 6.5) at $37^{\circ}C$, 100 rpm. In order to develop a sustained release preparation containing felodipine, a comparative dissolution study was done using commercial product as a control. The dissolution at 30 min of felodipine from $Eudragit^{(R)}$ RS or RL-coated pellets were 0.96% and 99.65, respectively. The weight ratio of $Eudragit^{(R)}$ RL pellets to RS pellets altered the dissolution rate, but did not optimize the dissolution rate. However, the sustained dissolution of felodipine from pellets was optimized by varying the coating ratios of $Eudragit^{(R)}$ RS. It is suggested that the coating ratio of pellets is the main factor which controls dissolution rate. Taken together, $Eudragit^{(R)}$ RS 30D-coated pellets showed the most comparable dissolution rate pattern to commercial product, $Splendil^{(R)}$. This sustained release pellets for oral delivery system of felodipine was simply manufactured, and drug release behavior was highly reproducible.

Physicochemical Characterization and Dissolution Properties of CS-891 with Different Crystallinity

  • Lee, Woo-Young;Park, Byoung-Woo;Park, Yong-Sun
    • Journal of Pharmaceutical Investigation
    • /
    • v.35 no.4
    • /
    • pp.279-285
    • /
    • 2005
  • Ground CS-891 (N-[1-(4-methoxyphenyl)-1-methylethyl]-3-oxo-4-aza-5a-androst-1-ene-$17{\beta}$-carboxamide) of poorly water soluble drug was obtained using a Heiko Seisakusho model TI-100 vibration mill, and samples with different crystallinity were prepared at mixture ratios of 10:0, 7:3, 5:5, 3:7 and 0:10 (intact;ground CS-891). Physicochemical characterizations were obtained using qualitative and quantitative X-ray diffractometry, different scanning calorimetry (DSC), scanning electron microscopy (SEM), Quantasorb surface area analyzer, and controlled atmosphere microbalance. With increase of amorphous CS-891 in mixture ratios, the intensities of X-ray diffraction peaks of crystalline CS-891 were decreased, whereas surface area, water absorption, and exothermic peaks in DSC were increased. The apparent solubility of ground CS-891 was $4.4\;{\mu}g/ml$ and the solubility of intact CS-891 was $3.1\;{\mu}g/ml$ at $37{\pm}1^{\circ}C$. The apparent precipitation rates of CS-891 in a supersaturated solution during the solubility test were increased with an increase of amorphous CS-891, and a crystalline form of CS-891 transformed from amorphous CS-891 after the solubility test was found by X-ray diffraction analysis, DSC and SEM. The dissolution profiles of CS-891 with different crystallinity at $37{\pm}1^{\circ}C$ by the USP paddle method were investigated, and the apparent dissolution rate constant of ground CS-891 was about 5.9-fold higher than that of intact CS-891. A linear relationships between the crystallinity of CS-891 and the apparent dissolution rate constant (r>0.96) were obtained.

Pharmacokinetic Evaluation of Flurbiprofen Sustained Release Capsule (플루르비프로펜 서방캅셀의 약물속도론적 평가)

  • Park, Kyoung-Ho;Lee, Min-Hwa;Yang, Min-Yeol;Lee, Chong-Won
    • Journal of Pharmaceutical Investigation
    • /
    • v.23 no.3
    • /
    • pp.179-186
    • /
    • 1993
  • In vitro dissolution test and pharmacokinetic study in human volunteers were conducted to evaluate the pharmacokinetic characteristics of 150 mg furbiprofen sustained-release capsule (FPSR-150). As a reference product, 50 mg flurbiprofen conventional-release capsule (FPCR-50) was used. Dissolution tests of two products were run using the paddle method in 450 : 540 (v/v %) mixture of simulated gastric and intestinal fluids (K.P. VI) by adjusting medium pH according to time. FPCR-50 was dissolved very rapidly, and it took about 1.5 hr for FPCR-50 to be dissolved over 90%, whereas 15 hr for FPSR-150. Also, in pharmacokinetic study, ten healthy male volunteers were administered one capsule of FPSR-150 or two capsules of FPCR-50 (FPCR-l00) with randomized two period cross-over study. Significant differences between FPCR-l00 and FPSR-150 were found in mean times to reach peak concentration, mean resident times and mean terminal phase halflives, while not in AUC/Dose (Student's t-test). In ANOVA for AUC/Dose to compare the bioavailabilities of two FP products, there was no significant difference. From the comparison of the simulated steady-state plasma concentration-time curves following multiple medications of FPCR-50 (3 capsules a day, dosing interval=8 hrs) and FPSR-150 (1 capsule a day) based on the above results obtained from single doses of two FP products, it was noted that the medication of FPSR-150 is more useful in clinical application rather than FPCR-50.

  • PDF